Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fluoroquinolone resistance in Ureaplasma parvum in the United States.

Literature DB >> 16597903

Fluoroquinolone resistance in Ureaplasma parvum in the United States.

Lynn Duffy¹, John Glass, Geraldine Hall, Robin Avery, Raymond Rackley, Scott Peterson, Ken Waites.

Abstract

We report the first case of naturally occurring fluoroquinolone resistance in Ureaplasma spp. from the United States. Resistance in this case probably developed as a result of mutations in the gyrA and parC genes of the DNA gyrase/topoisomerase IV complex that occurred in the presence of antimicrobial selective pressure.

Entities: Chemical Species

Mesh：

Substances：

Year: 2006 PMID： 16597903 PMCID： PMC1448668 DOI： 10.1128/JCM.44.4.1590-1591.2006

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

14 in total

1. DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones.

Authors: C M Bébéar; H Renaudin; A Charron; M Clerc; S Pereyre; C Bébéar
Journal: Antimicrob Agents Chemother Date: 2003-10 Impact factor: 5.191

2. Association of chronic urinary symptoms in women and Ureaplasma urealyticum.

Authors: J M Potts; A M Ward; R R Rackley
Journal: Urology Date: 2000-04 Impact factor: 2.649

3. Suboptimal efficacy of erythromycin and tetracycline against vaginal Ureaplasma urealyticum.

Authors: W R Bowie; V Willetts
Journal: Sex Transm Dis Date: 1987 Apr-Jun Impact factor: 2.830

4. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.

Authors: C M Bebear; H Renaudin; A Charron; D Gruson; M Lefrancois; C Bebear
Journal: Antimicrob Agents Chemother Date: 2000-09 Impact factor: 5.191

5. The complete sequence of the mucosal pathogen Ureaplasma urealyticum.

Authors: J I Glass; E J Lefkowitz; J S Glass; C R Heiner; E Y Chen; G H Cassell
Journal: Nature Date: 2000-10-12 Impact factor: 49.962

6. Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium.

Authors: S Dhandayuthapani; M W Blaylock; C M Bebear; W G Rasmussen; J B Baseman
Journal: J Bacteriol Date: 2001-10 Impact factor: 3.490

Review 7. Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors: Ken B Waites; Brenda Katz; Robert L Schelonka
Journal: Clin Microbiol Rev Date: 2005-10 Impact factor: 26.132

8. Etiologic role of Mycoplasma hominis and Ureaplasma urealyticum in women with the acute urethral syndrome.

Authors: W E Stamm; K Running; J Hale; K K Holmes
Journal: Sex Transm Dis Date: 1983 Oct-Dec Impact factor: 2.830

9. Study of isolation of fluoroquinolone-resistant Ureaplasma urealyticum and identification of mutant sites.

Authors: Wenbo Zhang; Yimou Wu; Weiguo Yin; Minjun Yu
Journal: Chin Med J (Engl) Date: 2002-10 Impact factor: 2.628

10. Bacteriuria due to ureaplasmas and other fastidious organisms during pregnancy: prevalence and significance.

Authors: G L Gilbert; S M Garland; K F Fairley; D M McDowall
Journal: Pediatr Infect Dis Date: 1986 Nov-Dec

11 in total

1. Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.

Authors: Ken B Waites; D M Crabb; Lynn B Duffy
Journal: Antimicrob Agents Chemother Date: 2009-03-02 Impact factor: 5.191

2. In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.

Authors: Yasuhiro Kawai; Yukiko Nakura; Tetsu Wakimoto; Makoto Nomiyama; Tsugumichi Tokuda; Toshimitsu Takayanagi; Jun Shiraishi; Kenshi Wasada; Hiroyuki Kitajima; Tomio Fujita; Masahiro Nakayama; Nobuaki Mitsuda; Isao Nakanishi; Makoto Takeuchi; Itaru Yanagihara
Journal: Antimicrob Agents Chemother Date: 2015-02-02 Impact factor: 5.191

3. Rapid detection of a point mutation in the parC gene associated with decreased susceptibility to fluoroquinolones in Mycoplasma bovis.

Authors: I Lysnyansky; I Mikula; I Gerchman; S Levisohn
Journal: Antimicrob Agents Chemother Date: 2009-08-31 Impact factor: 5.191

4. Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.

Authors: Li Xiao; Donna M Crabb; Lynn B Duffy; Vanya Paralanov; John I Glass; Ken B Waites
Journal: Antimicrob Agents Chemother Date: 2012-02-27 Impact factor: 5.191

5. Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States.

Authors: Javier Fernández; Melissa J Karau; Scott A Cunningham; Kerryl E Greenwood-Quaintance; Robin Patel
Journal: Antimicrob Agents Chemother Date: 2016-07-22 Impact factor: 5.191

6. In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas.

Authors: Ken B Waites; Donna M Crabb; Lynn B Duffy; Michael D Huband
Journal: Antimicrob Agents Chemother Date: 2015-03-30 Impact factor: 5.191

7. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.

Authors: Ken B Waites; Donna M Crabb; Lynn B Duffy
Journal: Antimicrob Agents Chemother Date: 2008-07-28 Impact factor: 5.191

8. Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors: Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal: Antimicrob Agents Chemother Date: 2009-03-09 Impact factor: 5.191

9. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum in asymptomatic women in Northern Greece.

Authors: Tz Kotrotsiou; M Exindari; E Diza; G Gioula; A Melidou; K Kaplanis; N Malisiovas
Journal: Hippokratia Date: 2013-10 Impact factor: 0.471

10. Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.

Authors: Michael L Beeton; Victoria J Chalker; Lucy C Jones; Nicola C Maxwell; O Brad Spiller
Journal: Antimicrob Agents Chemother Date: 2015-10-12 Impact factor: 5.191